| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/08/2014 | US8691948 Methods and compositions for treating brain diseases |
| 04/08/2014 | US8691947 Materials related to sodium/potassium adenosine triphosphatase and Src |
| 04/08/2014 | US8691946 Methods and compositions for soft tissue repair |
| 04/08/2014 | US8691945 Antimicrobial peptides |
| 04/08/2014 | US8691944 Fibronectin polypeptides and methods of use |
| 04/08/2014 | US8691943 Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa |
| 04/08/2014 | US8691942 N- and C- terminal substituted antagonistic analogs of GH-RH |
| 04/08/2014 | US8691941 Method for producing peptide |
| 04/08/2014 | US8691940 Relaxin polypeptides comprising non-naturally encoded amino acids |
| 04/08/2014 | US8691939 Compositions, methods, and kits for assaying complement activation |
| 04/08/2014 | US8691848 Inhibitors of caspases |
| 04/08/2014 | US8691773 Peptide compound with biological activity, its preparation and its applications |
| 04/08/2014 | US8691772 HSP60, HSP60 peptides and T cell vaccines for immunomodulation |
| 04/08/2014 | US8691771 Bi-specific fusion proteins for tissue repair |
| 04/08/2014 | US8691770 Method for processing microbiologically produced cyclic oligopeptides |
| 04/08/2014 | US8691769 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections |
| 04/08/2014 | US8691768 Methods of determining delta opioid receptor subtypes |
| 04/08/2014 | US8691767 Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses |
| 04/08/2014 | US8691766 Biglycan and related therapeutics and methods of use |
| 04/08/2014 | US8691765 Metallothionein based neuronal therapeutic and therapeutic methods |
| 04/08/2014 | US8691764 Inhibitors of NF-κB activity |
| 04/08/2014 | US8691763 Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection |
| 04/08/2014 | US8691762 Methods and assays for treating subjects with SHANK3 deletion, mutation or reduced expression |
| 04/08/2014 | US8691761 Somatostatin receptor 2 antagonists |
| 04/08/2014 | US8691760 Peptides, pharmaceutical compositions comprising same and uses thereof |
| 04/08/2014 | US8691759 Protease stabilized, acylated insulin analogues |
| 04/08/2014 | US8691758 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/08/2014 | US8691757 Hepatitis C virus inhibitors |
| 04/08/2014 | US8691756 Macrocycles and their uses |
| 04/08/2014 | US8691755 Pegylated C-peptide |
| 04/08/2014 | US8691753 Pseudodipeptides as MMP inhibitors |
| 04/08/2014 | US8691752 Protein product for treatment of infectious diseases and related inflammatory processes |
| 04/08/2014 | US8691751 Compounds containing a vascular disrupting agent |
| 04/08/2014 | US8691750 Lipids and compositions for intracellular delivery of biologically active compounds |
| 04/08/2014 | US8691749 Peptide and use thereof |
| 04/08/2014 | US8691748 Edible and biocompatible metal-organic frameworks |
| 04/08/2014 | US8691544 Material for separation of a biomolecule |
| 04/08/2014 | US8691283 Standardized bee venom preparation |
| 04/08/2014 | US8691273 Method for producing hydroxyapatite particles |
| 04/08/2014 | US8691268 Transdermal delivery using encapsulated agent released by ultrasound and/or heat |
| 04/08/2014 | US8691247 Skin rejuvenation cream |
| 04/08/2014 | US8691243 Protein-based Streptococcus pneumoniae vaccine |
| 04/08/2014 | US8691236 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
| 04/08/2014 | US8691231 Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies |
| 04/08/2014 | US8691230 Methods for inhibiting hematopoiesis with a hedgehog antagonist |
| 04/08/2014 | US8691229 Method of PLSCR inhibition for cancer therapy |
| 04/08/2014 | US8691218 Vermin extermination using lysozyme, salt or biological fragment thereof, or lysozyme-related peptide as an egg recognition pheromone |
| 04/08/2014 | US8691216 Methods of using regenerative cells to promote wound healing |
| 04/08/2014 | US8691213 Protein free formula |
| 04/08/2014 | US8691211 Suppression of immune response to factor VIII in hemophilia A patients |
| 04/08/2014 | US8691209 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 04/08/2014 | US8691206 Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide |
| 04/08/2014 | US8691205 Mono- and di-PEG IL-10 production; and uses |
| 04/08/2014 | US8691189 Method of colorectal cancer detection by using radiolabeled anti-GRP78 peptide |
| 04/08/2014 | US8690874 Composition and process for bone growth and repair |
| 04/08/2014 | DE202013009871U1 Pharmazeutische und therapeutische Verwendung von SAG(-S-Acetylglutathion) Pharmaceutical and therapeutic use of SAG (-S-acetyl glutathione) |
| 04/08/2014 | CA2638914C Formulations for a tight junction effector |
| 04/08/2014 | CA2540703C Methods and compositions for mycoplasma pneumoniae exotoxins |
| 04/08/2014 | CA2524229C Canine ghrh gene, polypeptides and methods of use |
| 04/08/2014 | CA2494348C Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 04/08/2014 | CA2492053C Peptides with antimicrobial properties and compounds containing same, particularly for preserving food |
| 04/08/2014 | CA2447576C Use of hmg fragment as anti-inflammatory agents |
| 04/08/2014 | CA2378402C Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 04/03/2014 | WO2014052848A1 Apyrase treatments |
| 04/03/2014 | WO2014052807A1 Methods for alleviating symptoms of multiple sclerosis based on apoaequorin-containing compositions |
| 04/03/2014 | WO2014052766A1 Hepatocyte growth factor mimics as therapeutic agents |
| 04/03/2014 | WO2014052611A1 Generation of new pancreatic beta cells |
| 04/03/2014 | WO2014052490A1 Methods of using fix polypeptides |
| 04/03/2014 | WO2014052461A1 Treatment of central nervous system (cns) injury |
| 04/03/2014 | WO2014052453A1 Oral therapy of necrotizing enterocolitis |
| 04/03/2014 | WO2014051567A1 Chimeric neuregulins and method of making and use thereof |
| 04/03/2014 | WO2014051168A1 Agent for enhancing immunity containing glutathione |
| 04/03/2014 | WO2014050908A1 Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production |
| 04/03/2014 | WO2014050717A1 Skin condition amelioration agent |
| 04/03/2014 | WO2014049588A1 A method for treatment of pulmonary fibrosis and diagnosis or prognosis of an aggressive pulmonary fibrosis phenotype |
| 04/03/2014 | WO2014049574A2 Methods for the stabilization of arterial plaque for the treatment of ischemic stroke and peripheral artery disease |
| 04/03/2014 | WO2014048976A1 Anti-acinetobacter baumannii immunogens |
| 04/03/2014 | WO2014047741A1 Peptide directed protein knockdown |
| 04/03/2014 | WO2014025199A3 Staphylococcal enterotoxin-derived superantigen mutant, fusion protein in which target-specific polypeptides are connected to the mutant and use thereof |
| 04/03/2014 | WO2014025198A3 Lfa3 mutant, fusion protein in which target-specific polypeptides are connected to the mutant or lfa3 cd2 binding region, and use thereof |
| 04/03/2014 | WO2014023952A3 Interleukin-18 inhibitor for use in prevention and treatment of osteoarthritis |
| 04/03/2014 | WO2014022283A3 Glycoprotein hormone long-acting superagonists |
| 04/03/2014 | WO2014018777A3 Blood factor monitoring assay and uses thereof |
| 04/03/2014 | WO2014018689A3 Novel monomeric yellow-green fluorescent protein from cephalochordate |
| 04/03/2014 | WO2014014918A3 X-ding-cd4 peptide |
| 04/03/2014 | WO2014012082A3 Multivalent heteromultimer scaffold design an constructs |
| 04/03/2014 | WO2014002038A4 The use of ret agonist molecules for haematopoietic stem cell expansion protocols and transplantation therapy and a ret agonist kit |
| 04/03/2014 | WO2013192238A3 Compositions and methods for treatment of diabetes |
| 04/03/2014 | WO2013057171A9 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii |
| 04/03/2014 | WO2012050892A3 Methods for stimulating, increasing or enhancing killing of a cell that expresses luteinizing hormone releasing hormone (lhrh) receptors |
| 04/03/2014 | WO2012044783A3 Method of achieving a thymosin beta 4 concentration in a human patient |
| 04/03/2014 | WO2012031046A3 Lipids suitable for liposomal delivery of protein-coding rna |
| 04/03/2014 | WO2011133474A3 Methods of predicting predisposition to or risk of kidney disease |
| 04/03/2014 | WO2010096838A3 Proproteins and methods of use thereof |
| 04/03/2014 | US20140094506 Use of light sensitive genes |
| 04/03/2014 | US20140094419 Injectable aqueous ophthalmic composition and method of use therefor |
| 04/03/2014 | US20140094418 Palatable ductile chewable veterinary composition |
| 04/03/2014 | US20140094416 Sparc angiogenic domain and methods of use |
| 04/03/2014 | US20140094410 Silk fibroin materials and use thereof |
| 04/03/2014 | US20140094408 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |